PHRMA
Based in DC
🤖
AI Overview
With $1.4M in lobbying spend across 27 quarterly filings, PHRMA is a significant lobbying presence.
$1.4M
Total Lobbying Spend
27
Quarterly Filings
1
Lobbying Firms Used
3
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $150K |
| 2020 | $200K |
| 2021 | $50K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $150K |
| 2025 | $200K |
Lobbying Firms
HORIZON GOVERNMENT AFFAIRS
What They Lobby For
- IPAB, Budget, 340B, Medicare Part D, Medicare Part B Issues, Medicare non-interference, Medicare Part D rebates, Importation of drugs
- 340B, Medicare Part D, Medicare Part B Issues, Medicare non-interference, Medicare Part D rebates, Importation of drugs, Drug pricing, LIS Copays.
- 340B, Medicare Part D, Medicare Part B Issues, Medicare non-interference, Medicare Part D rebates, Importation of drugs, Drug pricing.
- 340B, Medicare Part D, Medicare Part B Issues, Medicare non-interference, Medicare Part D rebates, Importation of drugs, Drug pricing, Coronavirus issues.
- 340B, Medicare Part D, Medicare Part B Issues, Medicare non-interference, Medicare Part D Rebates, Importation of Drugs, Drug Pricing, Coronavirus Issues.
- 340B, Medicare Part D, Medicare Part B Issues, Medicare non-interference, Medicare Part D Rebates, Importation of Drugs, Drug Pricing, Coronavirus Issues, Build Back Better legislation, TRIPs Waiver
- 340B, Medicare Part D, Medicare Part B Issues, Medicare non-interference, Medicare Part D Rebates, Importation of Drugs, Drug Pricing, Coronavirus Issues, Build Back Better legislation, TRIPs Waiver, FDA reauthorization legislation
- 340B, Medicare Part D, Medicare Part B Issues, Medicare non-interference, Medicare Part D Rebates, Importation of Drugs, Drug Pricing, Coronavirus Issues, Inflation Reduction Act, TRIPs Waiver, FDA reauthorization legislation
- 340B, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Coronavirus Issues, Inflation Reduction Act, TRIPs Waiver, insurance coverage issues and Inflation Reduction Act implementation, March-in rights - Biden Administration announcement, HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act, HR 7174, The EPIC Act.
- 340B, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Coronavirus Issues, Inflation Reduction Act, TRIPs Waiver, insurance coverage issues and Inflation Reduction Act implementation, March-in rights - Biden Administration announcement, HR 5378-LowerCosts, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act, HR 7174, The EPIC Act.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.